As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation? (LLY:NYSE)

Love Employee/iStock via Getty Images Investors Should Know: The GLP-1 and broader metabolic disease drug space is advancing rapidly, with next-generation oral formulations, triple-acting compounds,…